换一批BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.
第一作者：
Judith E,Carser
第一单位：
Centre for Cancer Research and Cell Biology, Queens University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, N. Ireland, UK.
作者：
医学主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);BRCA1蛋白质(BRCA1 Protein);队列研究(Cohort Studies);无病生存(Disease-Free Survival);女(雌)性(Female);基因表达(Gene Expression);人类(Humans);免疫组织化学(Immunohistochemistry);中年人(Middle Aged);多元分析(Multivariate Analysis);肿瘤, 腺和上皮(Neoplasms, Glandular and Epithelial);有机铂化合物(Organoplatinum Compounds);卵巢肿瘤(Ovarian Neoplasms);试验预期值(Predictive Value of Tests);回顾性研究(Retrospective Studies);存活率(Survival Rate);紫杉烷类(Taxoids)
DOI
10.1016/j.ygyno.2011.08.017
PMID
21920589
发布时间
2025-05-29
- 浏览21
Gynecologic oncology
492-8页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
